Trophoblast Retrieval and Isolation from the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia

Alan D. Bolnick, Rani Fritz, Chandni Jain, Leena Kadam, Jay M. Bolnick, Brian A. Kilburn, Manvinder Singh, Michael Peter Diamond, Sascha Drewlo, D. Randall Armant

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Congenital adrenal hyperplasia (CAH) is an autosomal recessive defect in cortisol biosynthesis that elevates fetal androgen levels to cause genital ambiguity and external genital masculinization in newborn females. Introducing dexamethasone in utero by 7 weeks gestation precludes virilization of affected females. However, identification of a male fetus prior to week 7 could avert the necessity of steroid treatment in half of pregnancies at risk of CAH. We recently introduced trophoblast retrieval and isolation from the cervix (TRIC), an approach that noninvasively isolate homogeneous trophoblast cells from pregnant women as early as 5 weeks gestation, using a Papanicolaou test. Here, we have used TRIC to correctly identify male fetal DNA when both parents were carriers of the mutation that produces CAH and previously produced an affected child. Trophoblast cells (1400) obtained by TRIC were assessed using immunocytochemistry with an antibody against the trophoblast-specific β subunit of human chorionic gonadotropin, which labeled 100% (17 of 17) of isolated cells, while none of the excluded maternal cervical cells were labeled. The isolated cells were examined by fluorescent in situ hybridization for chromosomes 18, X, and Y at a clinical cytogenetics laboratory, demonstrating 100% (18 of 18) of cells to be diploid 18/XY. Aliquots of DNA obtained from the isolated cells assayed for SRY and RNASEH genes by TaqMan assays confirmed a male fetus. This case study demonstrates the utility of TRIC to accurately identify fetal gender as a means of reducing the need for prophylactic administration of exogenous steroids in pregnancies at risk of CAH.

Original languageEnglish (US)
Pages (from-to)717-722
Number of pages6
JournalReproductive Sciences
Volume23
Issue number6
DOIs
StatePublished - Jun 23 2016

Fingerprint

Congenital Adrenal Hyperplasia
Trophoblasts
First Pregnancy Trimester
Cervix Uteri
Pregnancy
Fetus
Steroids
Virilism
Chromosomes, Human, Pair 18
Papanicolaou Test
Disorders of Sex Development
DNA
Chorionic Gonadotropin
Diploidy
Fluorescence In Situ Hybridization
Cytogenetics
Dexamethasone
Androgens
Hydrocortisone
Pregnant Women

Keywords

  • 21-hydroxylase
  • congenital adrenal hyperplasia
  • fluorescence in situ hybridization
  • placenta
  • prenatal genetic diagnosis
  • steroids
  • trophoblast

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Trophoblast Retrieval and Isolation from the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia. / Bolnick, Alan D.; Fritz, Rani; Jain, Chandni; Kadam, Leena; Bolnick, Jay M.; Kilburn, Brian A.; Singh, Manvinder; Diamond, Michael Peter; Drewlo, Sascha; Armant, D. Randall.

In: Reproductive Sciences, Vol. 23, No. 6, 23.06.2016, p. 717-722.

Research output: Contribution to journalArticle

Bolnick, Alan D. ; Fritz, Rani ; Jain, Chandni ; Kadam, Leena ; Bolnick, Jay M. ; Kilburn, Brian A. ; Singh, Manvinder ; Diamond, Michael Peter ; Drewlo, Sascha ; Armant, D. Randall. / Trophoblast Retrieval and Isolation from the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia. In: Reproductive Sciences. 2016 ; Vol. 23, No. 6. pp. 717-722.
@article{1628c80292da4a3a9759c9289fa5bd5a,
title = "Trophoblast Retrieval and Isolation from the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia",
abstract = "Congenital adrenal hyperplasia (CAH) is an autosomal recessive defect in cortisol biosynthesis that elevates fetal androgen levels to cause genital ambiguity and external genital masculinization in newborn females. Introducing dexamethasone in utero by 7 weeks gestation precludes virilization of affected females. However, identification of a male fetus prior to week 7 could avert the necessity of steroid treatment in half of pregnancies at risk of CAH. We recently introduced trophoblast retrieval and isolation from the cervix (TRIC), an approach that noninvasively isolate homogeneous trophoblast cells from pregnant women as early as 5 weeks gestation, using a Papanicolaou test. Here, we have used TRIC to correctly identify male fetal DNA when both parents were carriers of the mutation that produces CAH and previously produced an affected child. Trophoblast cells (1400) obtained by TRIC were assessed using immunocytochemistry with an antibody against the trophoblast-specific β subunit of human chorionic gonadotropin, which labeled 100{\%} (17 of 17) of isolated cells, while none of the excluded maternal cervical cells were labeled. The isolated cells were examined by fluorescent in situ hybridization for chromosomes 18, X, and Y at a clinical cytogenetics laboratory, demonstrating 100{\%} (18 of 18) of cells to be diploid 18/XY. Aliquots of DNA obtained from the isolated cells assayed for SRY and RNASEH genes by TaqMan assays confirmed a male fetus. This case study demonstrates the utility of TRIC to accurately identify fetal gender as a means of reducing the need for prophylactic administration of exogenous steroids in pregnancies at risk of CAH.",
keywords = "21-hydroxylase, congenital adrenal hyperplasia, fluorescence in situ hybridization, placenta, prenatal genetic diagnosis, steroids, trophoblast",
author = "Bolnick, {Alan D.} and Rani Fritz and Chandni Jain and Leena Kadam and Bolnick, {Jay M.} and Kilburn, {Brian A.} and Manvinder Singh and Diamond, {Michael Peter} and Sascha Drewlo and Armant, {D. Randall}",
year = "2016",
month = "6",
day = "23",
doi = "10.1177/1933719116632922",
language = "English (US)",
volume = "23",
pages = "717--722",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "6",

}

TY - JOUR

T1 - Trophoblast Retrieval and Isolation from the Cervix for Noninvasive, First Trimester, Fetal Gender Determination in a Carrier of Congenital Adrenal Hyperplasia

AU - Bolnick, Alan D.

AU - Fritz, Rani

AU - Jain, Chandni

AU - Kadam, Leena

AU - Bolnick, Jay M.

AU - Kilburn, Brian A.

AU - Singh, Manvinder

AU - Diamond, Michael Peter

AU - Drewlo, Sascha

AU - Armant, D. Randall

PY - 2016/6/23

Y1 - 2016/6/23

N2 - Congenital adrenal hyperplasia (CAH) is an autosomal recessive defect in cortisol biosynthesis that elevates fetal androgen levels to cause genital ambiguity and external genital masculinization in newborn females. Introducing dexamethasone in utero by 7 weeks gestation precludes virilization of affected females. However, identification of a male fetus prior to week 7 could avert the necessity of steroid treatment in half of pregnancies at risk of CAH. We recently introduced trophoblast retrieval and isolation from the cervix (TRIC), an approach that noninvasively isolate homogeneous trophoblast cells from pregnant women as early as 5 weeks gestation, using a Papanicolaou test. Here, we have used TRIC to correctly identify male fetal DNA when both parents were carriers of the mutation that produces CAH and previously produced an affected child. Trophoblast cells (1400) obtained by TRIC were assessed using immunocytochemistry with an antibody against the trophoblast-specific β subunit of human chorionic gonadotropin, which labeled 100% (17 of 17) of isolated cells, while none of the excluded maternal cervical cells were labeled. The isolated cells were examined by fluorescent in situ hybridization for chromosomes 18, X, and Y at a clinical cytogenetics laboratory, demonstrating 100% (18 of 18) of cells to be diploid 18/XY. Aliquots of DNA obtained from the isolated cells assayed for SRY and RNASEH genes by TaqMan assays confirmed a male fetus. This case study demonstrates the utility of TRIC to accurately identify fetal gender as a means of reducing the need for prophylactic administration of exogenous steroids in pregnancies at risk of CAH.

AB - Congenital adrenal hyperplasia (CAH) is an autosomal recessive defect in cortisol biosynthesis that elevates fetal androgen levels to cause genital ambiguity and external genital masculinization in newborn females. Introducing dexamethasone in utero by 7 weeks gestation precludes virilization of affected females. However, identification of a male fetus prior to week 7 could avert the necessity of steroid treatment in half of pregnancies at risk of CAH. We recently introduced trophoblast retrieval and isolation from the cervix (TRIC), an approach that noninvasively isolate homogeneous trophoblast cells from pregnant women as early as 5 weeks gestation, using a Papanicolaou test. Here, we have used TRIC to correctly identify male fetal DNA when both parents were carriers of the mutation that produces CAH and previously produced an affected child. Trophoblast cells (1400) obtained by TRIC were assessed using immunocytochemistry with an antibody against the trophoblast-specific β subunit of human chorionic gonadotropin, which labeled 100% (17 of 17) of isolated cells, while none of the excluded maternal cervical cells were labeled. The isolated cells were examined by fluorescent in situ hybridization for chromosomes 18, X, and Y at a clinical cytogenetics laboratory, demonstrating 100% (18 of 18) of cells to be diploid 18/XY. Aliquots of DNA obtained from the isolated cells assayed for SRY and RNASEH genes by TaqMan assays confirmed a male fetus. This case study demonstrates the utility of TRIC to accurately identify fetal gender as a means of reducing the need for prophylactic administration of exogenous steroids in pregnancies at risk of CAH.

KW - 21-hydroxylase

KW - congenital adrenal hyperplasia

KW - fluorescence in situ hybridization

KW - placenta

KW - prenatal genetic diagnosis

KW - steroids

KW - trophoblast

UR - http://www.scopus.com/inward/record.url?scp=84966738938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966738938&partnerID=8YFLogxK

U2 - 10.1177/1933719116632922

DO - 10.1177/1933719116632922

M3 - Article

VL - 23

SP - 717

EP - 722

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 6

ER -